Pulmonary catheter study proposals to be reviewed by NHLBI advisory board Sept. 4.
This article was originally published in The Gray Sheet
PULMONARY ARTERY CATHETER RESEARCH PROPOSALS TO BE REVIEWED BY NHLBI advisory board on Sept. 4. The National Heart, Lung and Blood Institute's advisory panel is slated to review research proposals developed at an Aug. 25-26 workshop in Alexandria, Virginia sponsored by FDA and the National Institutes of Health to address questions about the safety and effectiveness of pulmonary artery catheters.
You may also be interested in...
Pulmonary artery catheterization (PAC) of severe heart failure patients is not associated with lower mortality, although it may assist doctors in improving patient quality of life, according to ESCAPE trial findings
Biopharma is working on a reputation renaissance as the public looks to industry for treatments and vaccines for the COVID-19 epidemic and drug pricing concerns take a back seat.